Literature DB >> 3841752

Hashimoto's thyroiditis and carcinoma of the thyroid gland.

K Segal, M Ben-Bassat, A Avraham, G Har-El, J Sidi.   

Abstract

Seven cases of Hashimoto's disease (HT) occurring in association with carcinoma of the thyroid gland are presented. The diagnosis of HT was not reached before surgery in any of the cases; it was an incidental histopathological finding. There was no case of pure papillary cancer: two specimens showed mixed papillary and follicular cancers, four revealed follicular carcinomas (one of them with anaplastic areas) and one medullary neoplasm. Other authors, however, have reported that pure papillary carcinoma occurred with significantly greater frequency in thyroids also displaying Hashimoto's disease. Total thyroidectomy was performed in all seven patients and one patient with anaplastic follicular cancer also received external irradiation. TSH suppressive therapy was given postoperatively. All these patients are alive with no evidence of further disease after seven to 17 years of follow-up study, whereas the mortality in our total series of thyroid cancers, even in patients with low-grade malignancy, was about 9%. Thus the prognosis of patients with carcinoma of the thyroid gland with coexisting Hashimoto's disease is better than that of patients with carcinoma of the thyroid gland alone. Hashimoto's thyroiditis does not seem to be a premalignant lesion. There was no evidence suggesting that thyroid carcinoma originated in the proliferating epithelium of Hashimoto's thyroiditis. It would appear that thyroid carcinoma stimulates the development of HT in some patients and that the presence of the autoimmune inflammatory reaction and the circulating antibodies retard growth and dissemination of carcinoma of the thyroid gland.

Entities:  

Mesh:

Year:  1985        PMID: 3841752

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  21 in total

1.  Loss of heterozygosity mutations of tumor suppressor genes in cytologically atypical areas in chronic lymphocytic thyroiditis.

Authors:  Jennifer L Hunt; Zubair W Baloch; Leon Barnes; Patricia A Swalsky; Cindy L Trusky; E Sesatomi; Sydney Finkelstein; Virginia A LiVolsi
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

2.  Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies.

Authors:  Joshua C Denny; Dana C Crawford; Marylyn D Ritchie; Suzette J Bielinski; Melissa A Basford; Yuki Bradford; High Seng Chai; Lisa Bastarache; Rebecca Zuvich; Peggy Peissig; David Carrell; Andrea H Ramirez; Jyotishman Pathak; Russell A Wilke; Luke Rasmussen; Xiaoming Wang; Jennifer A Pacheco; Abel N Kho; M Geoffrey Hayes; Noah Weston; Martha Matsumoto; Peter A Kopp; Katherine M Newton; Gail P Jarvik; Rongling Li; Teri A Manolio; Iftikhar J Kullo; Christopher G Chute; Rex L Chisholm; Eric B Larson; Catherine A McCarty; Daniel R Masys; Dan M Roden; Mariza de Andrade
Journal:  Am J Hum Genet       Date:  2011-10-07       Impact factor: 11.025

3.  Is diffuse and peritumoral lymphocyte infiltration in papillary thyroid cancer a marker of good prognosis?

Authors:  D G P N Villagelin; R B Santos; J H Romaldini
Journal:  J Endocrinol Invest       Date:  2011-07-13       Impact factor: 4.256

4.  Identification of functionally distinct TRAF proinflammatory and phosphatidylinositol 3-kinase/mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (PI3K/MEK) transforming activities emanating from RET/PTC fusion oncoprotein.

Authors:  Josephine H F Wixted; Jay L Rothstein; Laurence C Eisenlohr
Journal:  J Biol Chem       Date:  2011-12-09       Impact factor: 5.157

5.  The reliability of fine-needle aspiration biopsy in terms of malignancy in patients with Hashimoto thyroiditis.

Authors:  Murat Kapan; Akin Onder; Sadullah Girgin; Burak Veli Ulger; Ugur Firat; Omer Uslukaya; Abdullah Oguz
Journal:  Int Surg       Date:  2015-02

6.  Haemangiopericytoma of the thyroid gland in combination with Hashimoto's disease.

Authors:  T Hansen; A Gaumann; M Ghalibafian; A Höferlin; A Heintz; C J Kirkpatrick
Journal:  Virchows Arch       Date:  2004-07-09       Impact factor: 4.064

7.  Thyroid cancer: current molecular perspectives.

Authors:  Francesca Giusti; Alberto Falchetti; Francesco Franceschelli; Francesca Marini; Annalisa Tanini; Maria Luisa Brandi
Journal:  J Oncol       Date:  2010-03-29       Impact factor: 4.375

8.  Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?

Authors:  Hee Yong Kwak; Byung Joo Chae; Yong Hwa Eom; Young Ran Hong; Jae Beom Seo; So Hee Lee; Byung Joo Song; Sang Seol Jung; Ja Seong Bae
Journal:  Int J Clin Oncol       Date:  2014-10-15       Impact factor: 3.402

Review 9.  Is Hashimoto's thyroiditis a risk factor for medullary thyroid carcinoma? Our experience and a literature review.

Authors:  Ayman A Zayed; Moaath K Mustafa Ali; Omar I Jaber; Moh'd J Suleiman; Ashraf A Ashhab; Wajdi Mohammed Al Shweiat; Munther Suliaman Momani; Maha Shomaf; Salah Mohammed AbuRuz
Journal:  Endocrine       Date:  2014-07-24       Impact factor: 3.633

10.  The Relationship of Lymphocytic Thyroiditis to the Development of Thyroid Carcinoma.

Authors:  Isao Okayasu
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.